Tango Therapeutics Inc (TNGX)
9.35
+0.42
(+4.70%)
USD |
NASDAQ |
Jun 17, 10:28
Tango Therapeutics Cash and Short Term Investments (Quarterly): 343.60M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 343.60M |
| December 31, 2023 | 336.88M |
| September 30, 2023 | 359.88M |
| June 30, 2023 | 310.65M |
| March 31, 2023 | 333.64M |
| December 31, 2022 | 366.13M |
| Date | Value |
|---|---|
| September 30, 2022 | 393.29M |
| June 30, 2022 | 416.36M |
| March 31, 2022 | 449.88M |
| December 31, 2021 | 485.26M |
| September 30, 2021 | 503.80M |
| December 31, 2020 | 190.32M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
190.32M
Minimum
Dec 2020
503.80M
Maximum
Sep 2021
374.14M
Average
363.01M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cytokinetics Inc | 618.96M |
| Aquestive Therapeutics Inc | 95.20M |
| 2seventy bio Inc | 181.38M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |